Mineralys Therapeutics, Inc.'s total assets for Q3 2025 were $599.95M, an increase of 78.70% from the previous quarter. MLYS total liabilities were $23.52M for the fiscal quarter, a 6.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.